Osteoporosis, the loss of bone mass and structure, hastened by the unexpected drop in estrogen that occurs when a woman comes to menopause, whether in nature through surgery removing ovaries before of the 45 levels or premature menopause caused by breast cancer treatment. Estrogen keeps bones, hence the lack of estrogen is a factor of particular risk for osteoporosis.
Osteoporosis can occur in less than 45 years, or at any time later. It is particularly significant for women to inform breast cancer treatment experience of the risk factors, detection and prevention of osteoporosis.
Although the exact cause of breast cancer has not been identified, the risk of developing the increases with age. There is a high risk in women over age 60. Due to its age, these women are already at increased risk for osteoporosis. Given the growing incidence of the disease and the development of long-term survival rates, the prevention of bone health and the fracture have become important issues of health among their survivors.Both osteoporosis and invasive breast cancer often have no symptoms, provided the early stages of the disease. Postmenopausal women should be aware of your individual for each of these disease risks.Women who have had breast cancer treatment perhaps at increased risk of osteoporosis and break for a few reasons. First, the estrogen has a protective effect on bone, and lower levels of the hormone bone loss trigger. Due to chemotherapy, or surgery, many of their survivors feel a loss of ovarian function and as a result, a drop in estrogen levels. Women who were premenopausal before his cancer treatment tend to experience menopause before that those who have not had the disease.powerful chemotherapy drugs and block the estrógeno-tratamientos hormone are very effective in the treatment of breast cancer. But that could be put women at risk for other disease progression: osteoporosis.Premenopausal women treated for breast cancer, osteoporosis is a matter as well. The likely effect of chemotherapy in the bones, cancer treatment could stimulate early, making the Group at a similar age in menopausal women risk menopause.Certain medications used to treat breast cancer could help prevent osteoporosis. The drug tamoxifen is used to prevent estrogen feeds the development of cancer cells. But that doesn't stop the creation of the body of estrogen, such as the aromatase inhibitors tamoxifen has been exposed to add to the bone density in postmenopausal women. Tamoxifen is used by women who have been diagnosed with cancer, as well as women at high risk of disease. In addition, the drug raloxifene, applied to treat osteoporosis, was recently found to be effective in the prevention of cancer in women at high risk.
